A Weird Tale of Politics & Pot
A DC lobbyist...filed a suit claiming that John Boehner and an associated law firm had stolen his idea, and the plans for implementing it, without giving him credit (or paying him)
Select Page
by C. Scott McMillin | Sep 15, 2022 | In the News | 0 |
A DC lobbyist...filed a suit claiming that John Boehner and an associated law firm had stolen his idea, and the plans for implementing it, without giving him credit (or paying him)
by C. Scott McMillin | Sep 5, 2022 | In the News | 0 |
by C. Scott McMillin | Aug 29, 2022 | Addictive Substances, Public Policy | 0 |
by C. Scott McMillin | Jul 25, 2022 | Thinking About Addiction | 0 |
by C. Scott McMillin | Jul 21, 2022 | In the News | 0 |
by C. Scott McMillin | Jun 2, 2022 | In the News | 0 |
by C. Scott McMillin | May 30, 2022 | Addictive Substances | 0 |
…one past error has been to overemphasize the more glamorous supply side interventions – interdiction and law enforcement – while paying much less attention to the demand side of the bargain.
Read Moreby C. Scott McMillin | May 26, 2022 | In the News | 0 |
By the time the authorities get around to questioning it, you’ll have collected more than enough revenue to pay your legal fees.
Read Moreby C. Scott McMillin | May 23, 2022 | Public Health | 0 |
P2P meth seemed to accelerate the curve of meth addiction, so that the user deteriorated far more quickly than in the past. And suffered worse consequences – in particular, a kind of extreme mental toxicity
Read Moreby C. Scott McMillin | May 16, 2022 | Addictive Substances | 0 |
Anyway, the emphasis now, especially with so many states having legalized recreational use, appears to on making sure there is THC in the widest possible range of commercial products, including at “breakfast, lunch, dinner, and snacktime,” said one sales exec.
Read Moreby C. Scott McMillin | Feb 17, 2022 | Public Policy | 0 |
The smaller, local, independent, licensed growers – intended to benefit from legalization– have instead found themselves all but shut out of the market, unable to compete with much cheaper offerings.
Read Moreby C. Scott McMillin | Feb 7, 2022 | In the News | 0 |
A functioning pill mill can be extraordinarily lucrative for those who own or operate them. The profits go untaxed, remember.
Read Moreby C. Scott McMillin | Jan 17, 2022 | In the News | 0 |
In COVID terms, it’s as contagious as omicron, as fatal as delta. And targeted at the young, making use of their favorite platforms.
Read Moreby C. Scott McMillin | Dec 27, 2021 | Public Policy | 0 |
…it’s foolish to expect an industry built around making, distributing, and selling (for immense profit) abusable substances to regulate themselves.
Read Moreby C. Scott McMillin | Nov 29, 2021 | In the News | 0 |
If so many players were involved, how can drug makers bear primary responsibility? Even if to the layperson’s mind, they richly deserve it.
Read Moreby C. Scott McMillin | Oct 28, 2021 | Addictive Substances | 0 |
Some genuinely bad news: a larger-than-usual share of the fakes are likely to exceed the two-milligram threshold for a potentially lethal dose of fentanyl. As many as two in five, according to DEA.
Read Moreby C. Scott McMillin | Sep 6, 2021 | In the News | 0 |
Now this really sounds like what we heard from Purdue Pharma in the early days of the Oxycontin epidemic.
Read Moreby C. Scott McMillin | Jul 22, 2021 | Public Policy | 0 |
“Holy crap! What happened?” the public demands. Followed by “Who’s to blame?” Not us, insist the makers and distributors.
Read More